DCN suppresses tumor cell-mediated angiogenesis by inhibiting the endogenous production of vascular endothelial cell growth factor [35], similar to neutralizing antibodies directed toward the epidermal growth factor receptor (EGFR) [36]. Here, EGFR is linked to neoplasm.